Harmony Transcatheter Pulmonary Valve (TPV) System

FDA approval for implant to treat congenital heart disease

The U.S. Food and Drug Administration approved the first in the world non-surgical heart valve to treat pediatric and adult patients with a native or surgically-repaired right ventricular outflow tract (RVOT).

The device, called the Harmony Transcatheter Pulmonary Valve (TPV) System, is intended to improve blood flow to the lungs in patients with severe pulmonary valve regurgitation without open-heart surgery, which is the current standard of care. The use of the Harmony valve may delay the time before a patient needs additional open-heart surgery. It can also potentially reduce the total number of open-heart surgeries required over an individual’s lifetime. More details on the FDA website.

26.03.2021

AI making earlier detection of colorectal cancer possible

Early detection is crucial for effective treatment of colorectal cancer, but the initial stages are easily missed during endoscopy screenings. With GI Genius, Medtronic presents an AI-powered tool to…

Article • New tools for the OR

Promoting ‘robot readiness’ in surgery

Using surgical robotic systems in OR settings brings many benefits, but there are also challenges that must be overcome before implementing the systems into surgical routine. We spoke with Megan…

Article • Cardiac device

The pioneering mini-pacemaker

A pioneering new generation of wireless mini-pacemaker is set to benefit many more patients than before. Following a successful first-in-Europe implantation procedure at the University Hospitals of…